Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Pre-close Trading Statement

3 Apr 2008 07:00

Marston's PLC03 April 2008 3 April 2008 Marston's PLC Pre-Close Trading Statement The Board of Marston's PLC issues the following trading update following the endof the first half of the current financial year on 29 March 2008. Trading In Marston's Inns & Taverns, our managed pub division, like-for-like sales forthe 24 weeks to 15 March 2008* were 0.3% above last year against strongcomparatives, with reported like-for-like sales growth of 7.0% for the sameperiod last year. Food sales have continued to show excellent like-for-likesales growth of 7.8% in the same 24 week period, although higher margin wetsales and machine income were 3.1% and 10.3% below last year respectively. Ournew build programme continues to generate attractive returns with 8 new pubsopened in the first half-year, and we expect to open a further 12 in the secondhalf-year. In Marston's Pub Company, our tenanted and leased pub division, like-for-likeprofit was slightly below last year in the period with growth in rental incomeoffset by volumes and machine income in line with market trends. In Marston's Beer Company, whilst overall volumes remain below last year we haveincreased market share with continued good performance in the premium alesegment. Costs across the Group have been well controlled, notwithstanding inflationarypressures in brewing and food purchasing, but the changes in sales mix describedabove will continue to have an impact on operating margins. In our interim results statement due to be issued on 23 May 2008 we expect toreport Group sales up by around 4% compared to last year for the 26 week period,reflecting the acquisitions of Sovereign Inns, Eldridge Pope and RingwoodBrewery in 2007. Operating profit (before interest and taxation) is expected tobe in line with last year, although profit before taxation will reflect thehigher interest costs associated with the £150 million share buy-back programmein 2007. Earnings per share will also reflect the related reduction of around9.5% in the average number of shares in issue and an expected lower underlyingrate of taxation. Underlying cash generation remains strong with net debtestimated to be approximately £1.27 billion at the half year-end. Outlook We remain cautious about the outlook for 2008, and the recent increase in beerduty adds to the pressures on tenants and free trade operators in an alreadychallenging trading environment. However with our high quality pub estate and our continuing investment innew-build pubs, we are well positioned to exploit favourable trends includingmarket growth in casual dining, and our value for money offers and mid-marketposition are well suited to the current economic climate. Notwithstanding thecurrent testing market conditions our expectations for the financial year as awhole remain unchanged. * In 2007 Easter fell in the second half-year. Like-for-like sales are reportedfor the 24 week period in order to be on a comparable basis to last year. ENQUIRIES:Marston's, PLC Hudson SandlerRalph Findlay, Chief Executive Andrew HayesPaul Inglett, Finance Director Nick LyonTel: 01902 329516 James White Tel: 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Oct 20183:21 pmRNSTotal Voting Rights
21st Sep 20183:04 pmRNSHolding(s) in Company
20th Sep 201810:21 amRNSHolding(s) in Company
19th Sep 20188:12 amRNSDirector Declaration
17th Sep 20189:57 amRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSAppointment of Chairman
5th Sep 20182:00 pmRNSHolding(s) in Company
21st Aug 20189:07 amRNSHolding(s) in Company
14th Aug 20189:29 amRNSHolding(s) in Company
7th Aug 201812:23 pmRNSDirector/PDMR Shareholding
2nd Aug 20188:46 amRNSDirector Declaration
31st Jul 20187:30 amRNSDirector Declaration
25th Jul 20182:15 pmRNSDirector Declaration
25th Jul 20187:00 amRNSTrading Update
19th Jul 20188:47 amRNSDirector Declaration
10th Jul 20181:38 pmRNSBlock listing Interim Review
3rd Jul 20182:19 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results
27th Nov 20177:00 amRNSDirectorate
1st Nov 20171:17 pmRNSTotal Voting Rights
10th Oct 20177:00 amRNSYear-End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.